|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) | ||
| A61P 9/00 | (2006.01) |
| (11) | Number of the document | 3794122 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19728800.4 |
| Date of filing the European patent application | 2019-05-14 | |
| (97) | Date of publication of the European application | 2021-03-24 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation | 2023-11-27 |
| (86) | Number | PCT/US2019/032150 |
| Date | 2019-05-14 |
| (87) | Number | WO 2019/222166 |
| Date | 2019-11-21 |
| (30) | Number | Date | Country code |
| 201862671094 P | 2018-05-14 | US | |
| 201862727141 P | 2018-09-05 | US | |
| 201962816996 P | 2019-03-12 | US |
| (72) |
FOSTER, Donald , US
HINKLE, Gregory , US
SCHLEGEL, Mark, K. , US
|
| (73) |
Alnylam Pharmaceuticals, Inc. ,
675 West Kendall Street
Henri A. Termeer Square, Cambridge, MA 02142,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Angiotenzinogeno (AGT) iRNR kompozicijos ir jų panaudojimo būdai |
| ANGIOTENSINOGEN (AGT) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 7 | 162.00 EUR |
| 2026-05-14 |